S.M. Böger
Institute of Clinical Pharmacology
Hannover Medical School
Germany
Name/email consistency: high
- Role of endogenous nitric oxide in circadian blood pressure regulation in healthy humans and in patients with hypertension or atherosclerosis. Bode-Böger, S.M., Böger, R.H., Kielstein, J.T., Löffler, M., Schäffer, J., Frölich, J.C. J. Investig. Med. (2000)
- Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Böger, R.H., Bode-Böger, S.M., Sydow, K., Heistad, D.D., Lentz, S.R. Arterioscler. Thromb. Vasc. Biol. (2000)
- LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Böger, R.H., Sydow, K., Borlak, J., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., Bode-Böger, S.M. Circ. Res. (2000)
- Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Böger, R.H., Bode-Böger, S.M. Semin. Thromb. Hemost. (2000)
- Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans. Böger, R.H. J. Endocrinol. Invest. (1999)
- Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. Böger, R.H., Bode-Böger, S.M., Thiele, W., Creutzig, A., Alexander, K., Frölich, J.C. J. Am. Coll. Cardiol. (1998)